|
|  |
Washington University in St. Louis News & Information > Faculty Experts at Washington University in St. Louis >
Director of the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research
Expertise: biodefense, infectious diseases
Bio:
 |
| Stanley |
Stanley directs the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE), funded by a $35 million grant from the National Institute of Allergy and Infectious Diseases. The center's mission is to support basic and translational research in critical areas of biodefense and emerging infectious diseases throughout the Midwest, which includes Missouri, Iowa, Nebraska and Kansas. The center will concentrate on expanding current research efforts in biodefense, identifying new areas of need in the field and expanding facilities to support biodefense research.
| News Stories & Tip Sheets: |
Showing Stories 1 through 5 of 9.
- Show More |
|
NIH extends biodefense funding
$37 million to extend regional biodefense and emerging infectious diseases research
June 24,
2009 -- The National Institutes of Health (NIH) has extended funding for the Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases (MRCE), anchored at the School of Medicine. The center received a five-year, $37 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue to support basic and translational research in biodefense and emerging infectious diseases throughout the Midwest.
|
NIH to set women's health research priorities
WU hosts public hearing, conference to help NIH prioritize women's health research
Feb. 16,
2009 -- What are your priorities for women's health research? The National Institutes of Health (NIH) wants to know. Washington University will host a national meeting March 4-6 on behalf of the NIH Office of Research in Women's Health as it begins to develop research priorities for the next decade.
|
????
Stanley targets infectious disease, helps faculty meet research goal
Feb. 1,
2008 -- Located smack in the middle of the United States, St. Louis seems an unlikely place to study tropical diseases typically found half a world away in Africa and Asia. But when Samuel L. Stanley Jr., M.D., came to Washington University as a fellow in 1983, he knew he wanted to devote his career to tropical diseases, having spent time treating patients in Africa as a Harvard medical student.
|
Research!America
Samuel Stanley named global health research ambassador
July 11,
2007 --
Samuel Stanley, vice chancellor of research, has been named an Ambassador in Research!America's Paul G. Rogers Society for Global Health Research. Stanley is now one of 50 of the nation's foremost global health experts who have joined forces to increase awareness about the critical need for greater U.S. public and private investment in research to improve global health.
|
DNA differences
Fever after smallpox vaccination tied to individual genetic variations
June 18,
2007 -- St. Louis researchers have identified common DNA variations that underlie susceptibility to fever after smallpox vaccination. Their finding is the first to link individual differences written into the genetic code with a vaccine-related complication - albeit a mild one. Most of the eight genetic alterations the scientists identified increased the likelihood of fever after smallpox vaccination. A few, however, reduced fever risk.
|
Showing Stories 1 through 5 of 9.
- Show More |
|
|
| |
|
Download
Email this page
Print ready page